Trial intelligence / Profile preview

Brain Indices of Stimulant Treatment in Youth with ADHD

NCT04170738Phase 4Completed

Start
Nov 2019
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of dextroamphetamine + amphetamine in attention deficit hyperactivity disorder (ADHD). Started Nov 2019; status: completed.

02

Drugs

dextroamphetamine + amphetamine
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on NCT04170738.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04170738.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call